Sort
39,280 grants matching “leukemia”
ECOG Specimen Banking
$896,176Robert L Comis · Frontier Sci & Technology Rsch Fdn, Inc · U24 · FY2009 · CA
Therapeutic Targeting of Human AML Stem Cells
$895,854Craig T. Jordan · University Of Colorado Denver · R35 · FY2023 · CA
Leadership, Planning and Evaluation
$895,353Caryn Lerman · University Of Southern California · P30 · FY2024 · CA
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
$895,061Mark A Watson · Washington University · U24 · FY2020 · CA
Chromatin Structure in Regulation of Mammalian Gene Expression
$895,040Ann Dean · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Nervous System Development and Plasticity
$894,820Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$894,296John F Dipersio · Washington University · R35 · FY2023 · CA
Novel computational strategies to deconvolute co-occurring conditions in Down syndrome
$893,680James Christopher Costello · University Of Colorado Denver · R01 · FY2025 · HD
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$893,343Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
Mechanisms of Mammalian Epigenome Reprogramming
$892,738Todd Scott Macfarlan · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$892,711Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2023 · CA
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$892,711Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2022 · CA
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$892,711Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2021 · CA
Enhancing ENCODE Through a Transcription Factor Tagging Approach to ChIP-seq
$892,438Kevin P White · University Of Chicago · RC2 · FY2011 · HG
Genome-Wide Predictors of Treatment-Related Toxicities
$892,235Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2011 · CA
Childhood Leukemia and Environmental Exposures
$892,145Patricia A Buffler · University Of California Berkeley · R01 · FY2008 · ES
Hematopoietic Chimerism after Stem Cell Allografts
$892,086Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2018 · CA
ECOG-ACRIN Biorepositories to Support NCTN
$891,547Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2020 · CA
Studies of other risk factors for radiosensitive tumors
$891,475Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY
$891,368University Of Pennsylvania · P01 · FY2003 · CA
Type 1 Diabetes-A Proposal for Prevention & Intervention
$891,359Antoinette M Moran · University Of Minnesota · U01 · FY2010 · DK
Mechanisms of Cellular Transformation by HTLV-1
$890,665Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$890,509Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Molecular strategies for early detection and targeting of cancer
$890,314Tannishtha Reya · University Of California, San Diego · R35 · FY2020 · CA
DISCOVERY OF NEW ANTICANCER AGENTS FROM NATURAL PRODUCTS
$889,966Wayne State University · U19 · FY2000 · CA